Timed-pregnant Sprague-Dawley (CD) outbred rats and New Zealand White rabbits were dosed by gavage with methacrylonitrile (MACR) in distilled water during major organogenesis. Rats were dosed on Gestational Days (GD) 6 through 15 (0, 5, 25, or 50 mg MACR/kg/day) and rabbits on GD 6 through 19 (0, 1, 3, or 5 mg MACR/kg/day). Maternal clinical status was monitored daily during treatment. At termination (GD 20, rats; GD 30, rabbits), confirmed-pregnant females (25-26 per group, rats; 17-22 per group, rabbits) were evaluated for clinical status and gestational outcome; each live fetus was examined for external, visceral, and skeletal malformations. In rats, no treatment-related maternal clinical signs or mortality were observed, nor was there any adverse effect on maternal body weight or food or water consumption. At necropsy, absolute, relative, and adjusted maternal liver weight was increased at the mid-and high-dose groups, an effect that may be indicative of induction of hepatic enzymes rather than toxicity. In the absence of any indication of maternal toxicity, the no-observed-adverse-effect level (NOAEL) for maternal toxicity in this study was 3=50 mg MACR/kg/day. The NOAEL for developmental toxicity in rats was also 2=50 mg MACR/kg/day. There was no effect of treatment on postimplantation loss, mean fetal body weight per litter, or morphological development. In rabbits, maternal mortality and clinical signs were not dose related. Maternal food consumption, body weight, and liver weight were not adversely affected by treatment. Thus, the maternal NOAEL was 3=5 mg MACR/kg/day. Maternal toxicity, including death, was observed 3=7.5 mg/kg/day in preliminary studies. The developmental NOAEL was also 3=5 mg MACR/kg/day. There was no adverse effect of treatment on postimplantation loss or fetal body weight. A significant decrease in the percentage male fetuses per litter was observed, although there was no effect on total live litter size, suggesting that the reduction in the ratio of live male fetuses 1 To whom correspondence should be addressed.
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in the high-dose group was not biologically significant. MACR had no adverse effect on morphological development. In summary, oral administration of MACR to rats and rabbits during organogenesis, at doses that did not cause persistent maternal toxicity (50 mg MACR/kg/day, rats; 5 mg MACR/kg/day, rabbits), also did not cause any adverse developmental effects. © 19% society of Toxicology. Aliphatic nitriles have a wide variety of uses in organic synthesis and in the chemical and pharmaceutical industry. Methacrylonitrile (MACR; 2-methyl-2-propenenitrile, CAS No. 126-98-7) is used in the preparation of plastics and coatings, and as a chemical intermediate in the preparation of acids, amides, amines, esters, and nitriles (Windholz, 1983) . In addition, MACR is being used as a replacement for acrylonitrile in the manufacture of carbonated beverage containers (Cosidine, 1974) . MACR has been identified as a component of the mainstream smoke of unfiltered cigarettes made from air-cured, flue-cured, or a blend of these tobaccos at 3 /xg/ cigarette (Baker et ai, 1984) .
Some evidence of reproductive toxicity of MACR has been previously reported in rats. Oral administration of MACR to pregnant Sprague-Dawley rats of 50 mg/kg/day during the first or second week of gestation, or 100 mg/kg/ day during the second week of gestation, caused a dosedependent decrease in maternal body weight gain (Villarreal et ai, 1988) . All MACR-treated rats failed to maintain pregnancy, possibly as a result of cyanide toxicity from a primary metabolite of MACR (Farooqui and Mumtaz, 1991; Farooqui et ai, 1992) . At necropsy, MACR-treated rats had dosedependent edema of the fallopian tubes.
In an NTP-sponsored developmental toxicity pilot study, MACR, at doses of 0, 10, 50, 75, 100, and 125 mgTkg/day, was administered by gavage to pregnant Sprague-Dawley (CD) rats on Gestational Day (GD) 6-15 (NTP, 1992a) . Signs of systemic toxicity, including rough coat, lethargy, and hunched posture, were noted in all animals at 5^50 mg/ kg/day, and increased in severity in a dose-related manner. No clinical signs of toxicity were noted at 10 mg/kg/day. Mortality or morbidity was observed in 11% (1/9), 50% (4/ 8) , and 60% (6/10) of the animals in the 75, 100, and 125 mg/kg/day dose groups, respectively. Maternal body weight was significantly decreased at 5=50 mg/kg/day, compared to controls. In addition, maternal weight gain during gestation was decreased in all MACR-dose groups, while maternal weight gain during treatment and corrected maternal weight gain were decreased at 3=50 mg/kg/day compared to controls. Totally resorbed litters were observed in 10% (1/10), 25% (1/4), and 50% (2/4) of the pregnant animals in the 10, 100, and 125 mg/kg/day groups, respectively, but not in the other groups. There was no effect on fetal body weight at any dose. Morphological development was not evaluated (NTP, 1992a) .
In another NTP-sponsored, developmental toxicity pilot study, MACR, at doses of 0, 5, 10, 25, 50 , and 75 mg/kg, was administered by gavage to pregnant New Zealand White rabbits on GD 6 through 19 (NTP, 1992b) . Signs of systemic toxicity were noted in all animals at 2=10 mg/kg/day. Six out of 10 animals in the 10 mg/kg/day group, and all animals at doses 2=25 mg/kg/day, were found dead or were euthanized for humane reasons within 3 hr after dosing on GD 6. Two additional animals in the 10 mg/kg/day group were found dead prior to the end of the dosing period. No developmental toxicity was noted at 5 mg/kg/day. One animal at 10 mg/kg/day aborted her litter on GD 22, leaving only one animal in that dose group to be evaluated on GD 30. Fetal body weight for that litter was 18% lower than control values. Based on these results, doses 3= 1 Omg/mg/kg/day MACR were considered to cause excessive maternal toxicity, while 5 mg/kg/day did not cause clear-cut effects. Accordingly, an additional study, evaluating doses of 0 and 7.5 mg/kg/day MACR administered to New Zealand White rabbits on GD 6 through 19, was conducted (NTP, 1992c) . All of the animals (9/9) in the 7.5 mg/kg/day group exhibited labored breathing and were dead or euthanized on GD 7. Thus, under the conditions of this study, 7.5 mg/kg/day MACR was excessively toxic to the does (NTP, 1992c) .
The wide use and production patterns of MACR make exposure to MACR likely both in the industrial setting and in the general population. The existing literature demonstrates the lack of adequate developmental toxicity data relative to MACR exposure. Accordingly, the present studies were conducted by the NTP to further characterize the maternal and developmental toxicity of MACR in Sprague-Dawley rats and New Zealand White rabbits, in order to have data from two species that were produced under the same laboratory conditions. In addition, MACR is structurally related to acrylonitrile, which has been shown in rats and hamsters to cause maternal and developmental toxicity (Murray et al., 1978; Willhite et al., 1981; Barlow and Sullivan, 1982) .
METHODS 2

Animals and Animal Husbandry
Rats. The experimental animals were Sprague-Dawley outbred albino rats (Crl:CD BR VAF/Plus).
3 Female rats weighed from 207 to 275 g on GD 0 (i.e., day of vaginal sperm detection). Animals were individually identified by tail tattoo 4 during a 7-day quarantine. After quarantine, individual females were placed overnight in the home cage of a singly housed male of the same stock for mating and then examined the next morning for the presence of a vaginal sperm (Hafez, 1970) . During the study, females were housed singly in solid-bottom, polycarbonate cages with stainless steel lids 5 and Ab-Sorb-Dri litter. 6 Food 7 and deionized/filtered water were provided ad libitum throughout the study. The light cycle (12 hr light, 12 hr dark), temperature, and relative humidity in the animal rooms were controlled and monitored 8 throughout the study. Temperature and humidity averaged 72°F and 55%, respectively. Estimated exchange rate for air in each animal room was 10-14 times per hour.
Rabbits. The experimental animals were New Zealand White (NZW) rabbits [Hra:(NZW)SPF]. 9 Female rabbits weighed 2.7 to 4.0 kg on GD 0 (i.e., day of insemination). Animals were quarantined 10 to 14 days and identified by coded ear tags provided by the supplier. During the study, females were housed in stainless-steel cages with mesh flooring. 10 Food" and deionized/filtered water were available ad libitum throughout the study. Animal rooms were equipped with automatic light cycles and controlled and monitored temperature and humidity as indicated above. Temperature and humidity averaged 67°F and 51%, respectively. Air exchange in the animal rooms was maintained as described above.
Females were artificially inseminated (Hafez, 1970) . To induce ovulation, females received an iv injection of Pregnyl (200 units/ml;0.1 ml/kg) 12 prior to insemination. Semen was collected from the males using an artificial vagina (Bredderman et al., 1964) in conjunction with a teaser female. Prior to insemination, the ejaculate was examined for sperm motility and density. Semen of good quality (i.e., no urine or blood), with a sperm count of approximately 180 million sperm/ml, was used to inseminate the female rabbits. Inseminated females were singly housed.
The rat and rabbit studies were conducted using a two-replicate design (13 animals per group per replicate). Mated or inseminated females were randomly assigned to dose groups using a randomization procedure stratified by body weight on GD 0, so that body weights were not significantly 2 (1) 16 (9) 1 (1) 1 (1) 1 (1) 1 (1) (7) 5 (4) 2 (2) 1 (1) 1 (1) 1 (1) 7 (5) 3 (2) 3 (3) 1 (1) 12 (6) 1 (1) 1 (1) 2 (1) 1 (1) 7 (5) 1 (1) 1 (1) 34 (12) 6 (4) 7 (7) 1 (1) 29 (8) 3 (3) 18 ( (1) 17 (8) 6 (4) 3 (3) 1 (1) 19 (7) 3 (1) 15 ( 
One dam in the 3 mg/kg/day dose group was found dead on GD 19; one doe in the 5 mg/kg/day group was found dead on GD 20. b Includes all dams pregnant at termination; mean ± SEM; GD, gestational day. c Weight change during gestation minus gravid uterine weight. different across dose groups within individual replicates in a study or for each completed study (Tables 1 and 4) .
Test Chemical and Treatment
Methacrylonitrile 13 (MACR; CAS No. 126-98-7), 96% pure, 14 was dissolved in deionized/distilled water. Dosing solutions were verified to be within ±10% of the theoretical concentration by gas chromatography prior to administration. Each dosing solution was coded so that treatment and examination of animals were performed without knowledge of the dose levels.
MACR solutions or distilled water (vehicle) were administered daily by gavage on GD 6 through 15 (rats) or 6 through 19 (rabbits). The actual volume administered (5 ml/kg, rats; 3 ml/kg, rabbits) was based on body weight taken daily during the dosing period. Doses of 0, 5, 25, and 50 mg/kg/day were chosen for the rat study, and doses of 0, 1, 3, or 5 mg/kg/day MACR were chosen for the rabbit study, based on the results of preliminary toxicity studies performed by the NTP (NTP, 1992a,b,c) .
Observations
Animals were weighed on GD 0 and daily during treatment (GD 6 through 15, rats; GD 6 through 19, rabbits). Food and water (rats only) consumption 13 Obtained by Research Triangle Institute through the sponsor, from Fluka Chemical Corporation, Ronkonkoma, NY.
14 Purity determinations were conducted by Research Triangle Institute (NIEHS Contract NOl-ES-45061) gas chromatography. Identity and purity were confirmed by the Teratology Laboratory at RTI (NIEHS Contract NO1-ES-55080) using infrared spectroscopy and gas chromatography, respectively, upon receipt of the bulk compound and again following completion of the present studies (see NTP, 1993a,b) . was measured at 2-to 3-day intervals throughout the study, beginning on GD 0. In both studies, clinical signs were recorded at least once daily during the treatment periods. Following termination by carbon dioxide asphyxiation (rats, GD 20) or an iv injection of euthanasia solution" (rabbits, GD 30), maternal liver weight and gravid uterine weight were measured. Uterine contents were evaluated for the number of implantation sites, resorptions, late fetal deaths [i.e., fetuses with discernible digits and weighing greater than 0.8 g (rats) or 10 g (rabbits), but displaying no vital signs at the time of uterine dissection], and live fetuses. The uterus was stained to reveal possible early resorptions (Salewski, 1964) when evidence of pregnancy was not apparent. Live fetuses were dissected from the uterus; rat fetuses were anesthetized by inducing hypothermia (Lumb and Jones, 1973; Blair, 1979) , whereas rabbit fetuses were killed with an ip injection of euthanasia solution. Each live fetus was weighed and examined for external morphological abnormalities; the viscera were then examined using a fresh tissue dissection technique (Staples, 1974; Stuckhardt and Poppe, 1984) . Half of the fetuses were decapitated prior to dissection, and the heads were fixed in Bouin's solution for free-hand sectioning and examination (Wilson, 1965) . All fetal carcasses were cleared and stained with Alcian blue/Alizarin red S (Marr et ai, 1988) and examined for skeletal malformations.
Statistical Analyses
Analyses of data were carried out using the General Linear Model (GLM) procedures in the SAS software library (SAS Institute, 1990a,b,c,d,e) . Prior to analysis, an arcsine-square root transformation was performed on all litter-derived percentage data (Snedecor and Cochran, 1967) . Dose-response relationships for selected measures were evaluated with the test for linear trend. Analysis of variance (ANOVA) was used to determine whether 15 Veterinary Laboratories Inc., Lenexa, KS, or Anthony Products Co., Arcadia, CA. significant dose effects, replicate effect, or dose X replicate interactions had occurred. Absence of a significant dose X replicate interaction indicated that the pooling of replicate data was valid. When ANOVA revealed a significant main effect for dose, then Williams' multiple comparison test (Williams, 1971 (Williams, , 1972 ) and Dunnett's test (Dunnett, 1955 (Dunnett, , 1964 were used to compare each compound-treated group to the concurrent control group (a -0.05). Nominal scale measures were analyzed by a test for linear trend on proportions and a \ 2 test f°r independence among treatment groups (Siegel, 1956) . When the x 2 test f°r independence revealed significant (p < 0.05) differences among groups, then a Fisher one-tailed exact probability test (a -0.05) was used for pairwise comparisons between each compoundtreated group and the concurrent control group.
RESULTS
Rats
No maternal deaths, morbidity, or distinctive clinical signs were observed (Table 1) . Neither was there any significant adverse effect on maternal body weight or weight change during or after exposure to MACR (Table 1) . There was no persistent adverse effect of treatment on maternal food and water consumption. Necropsy of maternal animals on GD 20 revealed no effect of treatment on gravid uterine weight, but maternal liver weight (i.e., absolute, relative, and adjusted) was increased at the mid-and high-dose levels ( Table  1) . Examination of the uteri demonstrated that 96-100% of the mated animals in the control through high-dose group were pregnant (Table 1) .
All pregnant animals in the 0, 5, 25, and 50 mg/kg/day dose groups had one or more live fetuses on GD 20 (Table  2 ). There were no differences between the MACR-treated groups and the control group in the average number of implantation sites per litter, postimplantation deaths per litter, live fetuses per litter, or mean fetal weight per litter (Table  2) . When fetal weight per litter was examined separately by sex, no treatment-related differences were observed (data not shown). There was no effect of treatment on the incidence of morphological abnormalities (Tables 2 and 3) .
Rabbits
One animal in the mid-dose group (3 mg/kg/day) and one animal in the high-dose group (5 mg/kg/day) died on GD 20 (Table 4) . Although clinical signs, including alopecia and resistance to dosing, were noted more frequently in the MACR-treated groups than in the control group, the incidence and severity of the signs were not dose related and did not change over the course of the study. Exposure to MACR at 1, 3, or 5 mg/kg/day did not adversely affect maternal food consumption, body weight, or body weight change (Table 4) . At necropsy, there was no effect of treatment on gravid uterine weight or maternal liver weight (Table 1). Examination of the uteri demonstrated that 75-92% of the inseminated animals in the control through high-dose group were pregnant (Table 4) .
At necropsy on GD 30, 5/20 (25%), 4/22 (18%), 4/17 (24%), and 3/18 (17%) of the pregnant animals in the con- (16) 6 (5) 3 (3) 6 (4) 2 (2) 4 (4) trol, low-, mid-, and high-dose groups, respectively, had 100% resorptions, but the effect was not dose related (Table  5) . There was no effect of treatment on the number of implantation sites per litter, percentage postimplantation loss per litter, live litter size, or mean fetal body weight per litter (Table 5 ). When mean fetal body weight per litter was examined separately by sex, no treatment-related differences were observed (data not shown). However, the percentage of male pups per litter was decreased at the high-dose compared to the control group (Table 5 ). The prevalence of external, visceral, or skeletal malformations or variations was not affected by MACR administration to the maternal animals during organogenesis (Tables 5 and 6 ).
DISCUSSION
Human exposure to methacrylonitrile occurs as a result of inhalation of cigarette smoke at 3^g/cigarette (Baker et al, 1984) , in the industrial setting (TWA, 1 ppm or 0.003 mg/kg/day; ACGIH, 1995), and possibly from carbonated drink containers. The current study was conducted to assess the developmental toxicity potential of methacrylonitrile when administered by gavage to Sprague-Dawley rats at levels of 0, 5, 25, or 50 mg/kg/day or to NZW rabbits at levels of 0, 1, 3, or 5 mg/kg/day.
There was no persistent maternal or developmental toxicity in rats at levels of methacrylonitrile as high as 50 mg/ kg/day. This study established a NOAEL for developmental toxicity in the absence of maternal toxicity of 50 mg/kg/ day MACR administered by gavage to pregnant SpragueDawley rats during organogenesis. Additional studies at higher doses would be necessary to determine if 50 mg/kg/ day was the true NOAEL for maternal and development toxicity for MACR in rats. The rabbit study establishes a NOAEL for developmental toxicity of 3=5 mg/kg/day MACR in the presence of marginal nondose-related maternal toxicity.
The present rat study suggests that the toxicity of MACR to Sprague-Dawley rats at 50 mg/kg/day is less than that observed in the preliminary toxicity study, wherein significant maternal toxicity, including dose-related incidence of clinical signs and decreased maternal body weight and weight gain, was observed at 50 mg/kg/day and above, and mortality at 75 mg/kg and higher (NTP, 1992a) . In the present study, changes in maternal food consumption were transient and indicative of an initial aversion to the treatment regimen, a conclusion supported by the absence of an effect on maternal body weight. Increases in liver weight may be indicative of induction of liver enzymes rather than a toxic reaction. Differences in maternal toxicity between this study and the preliminary study in rats (NTP, 1992a) are not readily explainable.
MACR at doses up to 50 mg/kg/day in the present study had no effect on postimplantation survival, fetal weight, or morphological development in rats. The results of this study also suggest that MACR is probably less potent to rats than acrylonitrile, which has been shown to cause reduced maternal weight gain, increased resorptions per litter, reduced fetal body weight, an increase in skeletal variations at 65 mg/kg/ day administered to rats during organogenesis (Murray et ai, 1978) , and to induce exencephaly, encephalocoeles, and rib fusions and bifurcations in hamsters exposed in utero to 80-120 mg acrylonitrile/kg ip on GD 8 (Willhite et al, 1981) .
The results of the present rabbit study confirm and extend the results of the preliminary toxicity studies conducted in rabbits (NTP, 1992b,c) . These two preliminary studies suggested that doses greater than 5 mg/kg/day, administered to NZW rabbits on GD 6-19, were excessively toxic to the dams, resulting in morbidity or mortality prior to completion of the dosing period, whereas doses of 5 mg/kg/day do not cause clear-cut maternal or developmental toxicity. In the present rabbit study, marginal but not dose-related maternal toxicity was observed at 3 and 5 mg/kg/day, but there was no clear-cut evidence of developmental toxicity. The observation of a reduction in the ratio of live male fetuses in the high-dose group, in the absence of a reduction in litter size, suggests that this effect is not biologically significant.
The present study provides maternal and developmental toxicity data for MACR in two species which, when viewed together with results of the preliminary studies, suggests that methacrylonitrile toxicity follows a very steep doseresponse curve. Other researchers have suggested that cyanide plays a role in determining MACR toxicity. In light of this, additional studies in both species, including maternal and fetal disposition, pharmacokinetic parameters, and maternal and fetal cyanide levels, would aid greatly in understanding the toxicity of this compound. Pharmacokinetic data would also be critical to relating these animal data to human risk assessment in the industrial setting.
